PETALING JAYA: Independent auditor Messrs PricewaterhouseCoopers (PwC) PLT has reported a material uncertainty that may cast significant doubt on Pharmaniaga Bhd
’s ability to continue as a going concern.
In a filing with Bursa Malaysia, PwC noted the pharmaceutical group had incurred a net loss of RM605.1mil, in its audit of Pharmaniaga’s financial statements for the financial year ended Dec 31, 2022 (FY22).
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
